Article ; Online: Angiotensin II
Bulletin of the National Research Centre, Vol 42, Iss 1, Pp 1-
a key mediator in the development of liver fibrosis and cancer
2018 Volume 7
Abstract: Abstract Background Liver fibrosis and its outcomes of cirrhosis and hepatocellular carcinoma are major worldwide health problems and due to the complicated molecular pathogenesis, the options for effective systemic cure are relatively restricted. ... ...
Abstract | Abstract Background Liver fibrosis and its outcomes of cirrhosis and hepatocellular carcinoma are major worldwide health problems and due to the complicated molecular pathogenesis, the options for effective systemic cure are relatively restricted. Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers, having well established safety profiles and low economic costs, may provide synergistic effects to existing chemotherapies by reducing angiotensin II-mediated angiogenesis, fibrogenesis, mitogenesis, metastasis, and oxidative stress. Conclusion These effects suggest angiotensin II inhibitors as promising agents for further clinical trials in the management of patients with fibrotic diseases. |
---|---|
Keywords | Fibrosis ; Hepatocellular carcinoma ; Renin-angiotensin system ; Angiotensin II ; Science ; Q |
Language | English |
Publishing date | 2018-11-01T00:00:00Z |
Publisher | SpringerOpen |
Document type | Article ; Online |
Database | BASE - Bielefeld Academic Search Engine (life sciences selection) |
Full text online
More links
Kategorien
Inter-library loan at ZB MED
Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.